FDA Events Calendar

Track upcoming clinical trials, regulatory milestones, and biotech events

June 2026

153 events

Sun

Mon

Tue

Wed

Thu

Fri

Sat

1

ABBV-706 (SEZ6 ADC)ABBV-706 (SEZ6 ADC)Iza-Bren/Izalontamab Brengitecan (BL-B01D1) (EGFR/HER3 Bispecific ADC)

2

18F-GP1 (GPIIb/IIIa Tracer)Revuforj/Revumenib (SNDX-5613) Post-Transplant Maintenance (Menin Inhibitor)Giredestrant (Estrogen Receptor Degrader)

3

AlloNK (AB-101) (NK Cell Therapy)

4

5

Ribupatide Oral (KAI-9531-T) (GLP-1/GIP Agonist)CLYM116 (Anti-APRIL Antibody)Paridiprubart (EB05) (TLR4 Antibody)

6

Retatrutide (Triple Receptor Agonist)PF-08653944 (GLP-1 Receptor Agonist)AlloNK® (AB-101) + rituximab

7

8

9

10

Velinotamig (BCMAxCD3) (T Cell Engager)

11

ELVN-001 Humacyte Acellular Tissue Engineered Vessel (ATEV™)European Hematology Association (EHA)

12

Etentamig (ABBV-383) (BCMAxCD3 Bispecific)EPKINLY/Epcoritamab-bysp (GEN3013) (CD3xCD20 Bispecific)Canvuparatide (MBX 2109)

13

KITE-753 (CAR-T Therapy)Revuforj/Revumenib (SNDX-5613) + Mezigdomide (CELMod) (Menin Inhibitor)Budoprutug (CD19 Antibody)

14

LB2501 (In Vivo CAR-T)Navenibart (Plasma Kallikrein Inhibitor)Atumelnant CRN04894 (ACTH antagonist)

15

16

17

18

AMT-260 Tebipenem HBr (previously SPR994): oral carbapenem

19

Welireg/Belzutifan (MK-6482) + Keytruda/Pembrolizumab (MK-3475) (HIF-2α/PD-1 Blockade)

20

Cytisinicline Tegoprubart (AT-1501)

21

22

23

24

25

26

27

28

29

ZORYVE® (roflumilast) Cream 0.3%LNTH-2501 (Ga 68 edotreotide)Oxylanthanum Carbonate (OLC)

30

NTX-253 (Muscarinic M4 PAM)Volixibat (IBAT Inhibitor)Nuzefatide Pevedotin (BT5528) (EphA2 BDC)

Clinical Read

Regulatory

Meetings & Presentations